Date

Title

View

20 May 20

4basebio AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

20 May 20

4basebio AG: Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio’s contribution receives funding from ‘la Caixa’ Banking Foundation

View View

15 May 20

4basebio AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

15 May 20

4basebio AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

View View

14 May 20

4basebio AG: 4basebio AG reports first quarter 2020 financial results

View View

30 Apr 20

4basebio AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

24 Apr 20

4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 – Financial Guidance Met

View View

22 Apr 20

4basebio AG: 4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection

View View

20 Apr 20

4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting

View View

09 Apr 20

4basebio AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

08 Apr 20

4basebio AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

16 Mar 20

4basebio AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View